S

SLDB

Solid Bioscience

5.39

-0.08-1.46%
Closed19:57 07/15 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

188.66M

164.94M

260.25M

232.38M

171.17M

Total Current Assets

157.30M

129.73M

219.64M

222.61M

158.90M

Total Non Current Assets

31.36M

35.20M

40.61M

9.77M

12.27M

Total Liabilities

51.42M

38.46M

48.59M

24.17M

39.08M

Total Current Liabilities

30.26M

14.52M

22.51M

23.60M

24.48M

Total Non Current Liabilities

21.16M

23.94M

26.08M

568.00K

14.60M

Total Equity

137.25M

126.48M

211.67M

208.21M

132.09M

Total Stockholders Equity

137.25M

126.48M

211.67M

208.21M

132.09M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

188.66M

164.94M

260.25M

232.38M

171.17M

Total Common Shares Outstanding

40.47M

20.39M

19.56M

7.36M

5.66M

Total Preferred Shares Outstanding

--

--

--

--

--